Ioannis D. Kyrochristos

发表

TITLE PAGE TITLE: Proof-of-concept pilot study on comprehensive spatiotemporal intra-patient heterogeneity for colorectal cancer with liver metastasis

Achilleas, P. Patsalis, K. Tsangaras, 2021 .

TITLE PAGE TITLE: Proof-of-concept pilot study on comprehensive spatiotemporal intra-patient heterogeneity for colorectal cancer with liver metastasis

Achilleas, Achilleos, P. Patsalis, 2021 .

Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology.

D. Roukos, D. Ziogas, Ioannis D. Kyrochristos, 2018, Drug discovery today.

Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.

D. Roukos, D. Ziogas, G. Glantzounis, 2018, Biomarkers in medicine.

Molecular landscape of pancreatic cancer: challenges and clinical implications.

D. Roukos, D. Ziogas, G. Glantzounis, 2017, Future oncology.

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.

I. Kyrochristos, D. Roukos, D. Ziogas, 2019, Drug discovery today.

Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapy

I. Kyrochristos, D. Roukos, D. Ziogas, 2018, Medicinal research reviews.

Precise predictive and therapeutic strategy for breast cancer.

D. Roukos, D. Ziogas, E. Lykoudis, 2018, Future oncology.

Longitudinal ctDNA profiling in precision oncology and immunο-oncology.

D. Thanos, P. Filis, D. Roukos, 2023, Drug discovery today.

Predictive and patient-monitoring biomarkers: precision in the management of colorectal cancer.

D. Roukos, D. Ziogas, A. Goussia, 2020, Biomarkers in medicine.

Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer

I. Kyrochristos, D. Roukos, D. Ziogas, 2019, Cancers.

Comprehensive intra-individual genomic and transcriptional heterogeneity: Evidence-based Colorectal Cancer Precision Medicine.

I. Kyrochristos, D. Roukos, Ioannis D. Kyrochristos, 2019, Cancer treatment reviews.

From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers

W. Cho, E. Felekouras, D. Roukos, 2017, International journal of molecular sciences.

Primary liver cancer genome sequencing: translational implications and challenges

E. Felekouras, D. Roukos, D. Ziogas, 2017, Expert review of gastroenterology & hepatology.

Gaucher disease and β-thalassemia: A rare coinheritance.

M. Argyropoulou, A. Zikou, E. Pappa, 2017, Blood cells, molecules & diseases.

From personalized to precision cancer medicine.

I. Kyrochristos, D. Roukos, D. Ziogas, 2020, Personalized medicine.

Precision in cancer pharmacogenomics.

D. Roukos, E. G. Baltagiannis, M. Mitsis, 2020, Pharmacogenomics.

Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.

I. Kyrochristos, D. Roukos, D. Ziogas, 2018, Biomarkers in medicine.

Breast cancer genome analysis in time and space: biomarker development strategy.

D. Roukos, D. Ziogas, E. Lykoudis, 2018, Biomarkers in medicine.

Novel translational therapeutic strategy by sequencing primary liver cancer genomes.

D. Roukos, D. Ziogas, G. Glantzounis, 2017, Future oncology.

Precision in personalized prediction-based medicine.

D. Roukos, D. Ziogas, Ioannis D. Kyrochristos, 2018, Personalized medicine.

Breakthrough cancer genome analysis in time and space: novel oncotargets and early drug development.

D. Roukos, D. Ziogas, E. Lykoudis, 2018, Pharmacogenomics.

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.

D. Roukos, D. Ziogas, Ioannis D. Kyrochristos, 2019, Drug Discovery Today.

Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology

D. Roukos, D. Ziogas, Ioannis D. Kyrochristos, 2018, Expert review of medical devices.